Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomasHiroshi Fuji, Tetsuo Nishimura, Haruo Yamashita et al.|Radiation Oncology|2013Cited by 28
Assessment of the Organ-dose Reduction and Secondary Cancer Risk Associated With the Use of Proton Beam Therapy and Intensity Modulated Radiation Therapy in Treatment of NeuroblastomaHiroshi Fuji, T. Nishimura, Uwe Schneider et al.|International Journal of Radiation Oncology*Biology*Physics|2012Cited by 0